Evidence map›Paper›PMID 39013980›Full record

ArticleScientific reports2024

Deep learning-based cell segmentation for rapid optical cytopathology of thyroid cancer.

Peter R Jermain, Martin Oswald, Tenzin Langdun, Santana Wright, Ashraf Khan, Thilo Stadelmann, Ahmed Abdulkadir, Anna N Yaroslavsky

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Peter R JermainAdvanced Biophotonics Laboratory, University of Massachusetts Lowell, Lowell, MA, USA.
Martin OswaldCentre for Artificial Intelligence, Zurich University of Applied Sciences, Winterthur, Switzerland.
Tenzin LangdunCentre for Artificial Intelligence, Zurich University of Applied Sciences, Winterthur, Switzerland.
Santana WrightAdvanced Biophotonics Laboratory, University of Massachusetts Lowell, Lowell, MA, USA.
Ashraf KhanDepartment of Pathology, UMASS Chan Medical School-Baystate, Springfield, MA, USA.
Thilo StadelmannCentre for Artificial Intelligence, Zurich University of Applied Sciences, Winterthur, Switzerland.
Ahmed AbdulkadirCentre for Artificial Intelligence, Zurich University of Applied Sciences, Winterthur, Switzerland.
Anna N YaroslavskyAdvanced Biophotonics Laboratory, University of Massachusetts Lowell, Lowell, MA, USA. Anna_Yaroslavsky@uml.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluorescence polarization (Fpol) imaging of methylene blue (MB) is a promising quantitative approach to thyroid cancer detection. Clinical translation of MB Fpol technology requires reduction of the data analysis time that can be achieved via deep learning-based automated cell segmentation with a 2D U-Net convolutional neural network. The model was trained and tested using images of pathologically diverse human thyroid cells and evaluated by comparing the number of cells selected, segmented areas, and Fpol values obtained using automated (AU) and manual (MA) data processing methods. Overall, the model segmented 15.8% more cells than the human operator. Differences in AU and MA segmented cell areas varied between - 55.2 and + 31.0%, whereas differences in Fpol values varied from - 20.7 and + 10.7%. No statistically significant differences between AU and MA derived Fpol data were observed. The largest differences in Fpol values correlated with greatest discrepancies in AU versus MA segmented cell areas. Time required for auto-processing was reduced to 10 s versus one hour required for MA data processing. Implementation of the automated cell analysis makes quantitative fluorescence polarization-based diagnosis clinically feasible.

Indexed as

Deep LearningThyroid NeoplasmsCytodiagnosisFluorescence PolarizationHumansImage Processing, Computer-AssistedMethylene BlueNeural Networks, ComputerThyroid GlandMethylene BlueAutomated cell segmentationCytopathologyFluorescence polarizationMethylene blueSemantic segmentationThyroid cancer

Identifiers

PMID39013980
PMCPMC11252353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.